|Title:||Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications||Authors:||Chang, Chia-Hui
Yang, Stephen Shei-Dei
|Keywords:||Adrenocortical scintigraphy; Drug discontinuation; I-131-6 β-iodomethyl-norcholesterol single photon emission computed tomography/computed tomography; Primary aldosteronism; Spironolactone||Issue Date:||2018||Source:||Ci ji yi xue za zhi = Tzu-chi medical journal||Journal Volume:||30||Journal Issue:||3||Abstract:||
Adrenocortical scintigraphy for patients with primary aldosteronism (PA) without discontinuation or modification of antihypertensive medications is of concern because of drug interference with the renin-angiotensin-aldosterone system. We report the surgical outcomes of patients with PA lateralized with adrenocortical scintigraphy without drug discontinuation or modification.
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.